Greenebaum Comprehensive Cancer Center

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Melanoma1 trial
• Myeloproliferative neoplasms1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 32 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Terminated1 trial

Lead sponsor

• Loxo Oncology, Inc.2 trials
• Eli Lilly and Company1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

  NCT04662255· Phase 3· Loxo Oncology, Inc.· Source

• Active, not recruiting

  Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT04666038· Phase 3· Loxo Oncology, Inc.· Source

• Active, not recruiting

  A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

  NCT01594723· Phase 2· Eli Lilly and Company· Source

Closed trials

• Terminated

  Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

  NCT04152018· Phase 1· Pfizer· Source